Justin B. Klee, Co-Chief Executive Officer at Amylyx Pharmaceuticals, Inc. (AMLX), sold 200,000 shares at $31.84 ($6.4M) on 2023-03-16, disclosed to the SEC on 2023-03-20.
Open-market sale of $6.4M AMLX by Co-Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.84 | 96,555 | $3.1M | 48.2% |
| 2 | $31.84 | 96,555 | $3.1M | 48.2% |
| 3 | $32.48 | 3,445 | $112K | 1.8% |
| 4 | $32.48 | 3,445 | $112K | 1.8% |
| Total | $31.86 avg | 200,000 | $6.4M | 100% |
| Filing → |
| AMLX | SELL | 2026-02-04 | $228K | — | Filing → |
| AMLX | SELL | 2026-01-20 | $3.8M | — | Filing → |
| AMLX | SELL | 2026-01-08 | $86K | — | Filing → |